Analyst firms · Morgan Stanley · NOV
Morgan Stanley NOV price target and rating history
NOV Inc. (NOV) · Consumer Discretionary
Morgan Stanley rates NOV Inc. (NOV) Overweight with a $24 price target, as of its latest action on Jan 4, 2023. It has published 3 rating actions on NOV since July 2021, including 2 upgrades and 0 downgrades. Across 3 firms with a NOV price target in the last 12 months, the median target is $21.
- Current rating
- Overweight
- Price target
- $24
- Median target, all firms
- $21
- Actions on NOV
- 3
Morgan Stanley price target on NOV
Every Morgan Stanley rating on NOV
- Jan 4, 2023
- Oct 11, 2021
- Jul 9, 2021
How other firms rate NOV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Capital One | Overweight | $26 | Jun 4, 2026 |
| Barclays | Underweight | $21 | May 7, 2026 |
| RBC Capital Markets | Sector Perform | $21 | Apr 14, 2026 |
Questions about Morgan Stanley and NOV
- What is Morgan Stanley's price target for NOV?
- Morgan Stanley's latest stated price target for NOV Inc. (NOV) is $24, from its action on Jan 4, 2023.
- What is Morgan Stanley's rating on NOV?
- Morgan Stanley rates NOV Overweight, a bullish rating, as of Jan 4, 2023.
- When did Morgan Stanley last change its view on NOV?
- On Jan 4, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $21 to $24.
- How does Morgan Stanley's NOV target compare with other analysts?
- Across 3 firms with a NOV price target in the last 12 months, the median target is $21.
More NOV rating histories
All Morgan Stanley ratingsNOV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.